Baillie Gifford & CO Twist Bioscience Corp Transaction History
Baillie Gifford & CO
- $128 Billion
- Q3 2025
A detailed history of Baillie Gifford & CO transactions in Twist Bioscience Corp stock. As of the latest transaction made, Baillie Gifford & CO holds 1,262,739 shares of TWST stock, worth $39.4 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,262,739
              Previous 775,687
              
        
           62.79%
        
      
          
        Holding current value
$39.4 Million
            Previous $28.5 Million
            
        
           24.52%
        
      
          
        % of portfolio
0.03%
            Previous 0.02%
          
        Shares
	  13 transactions
	
  Others Institutions Holding TWST
# of Institutions
266Shares Held
72.6MCall Options Held
60.8KPut Options Held
58K- 
    
      Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.4MShares$200 Million1.95% of portfolio
- 
    
      Artisan Partners Limited Partnership Milwaukee, WI5.85MShares$182 Million0.4% of portfolio
- 
    
      Vanguard Group Inc Valley Forge, PA5.83MShares$182 Million0.0% of portfolio
- 
    
      Black Rock Inc. New York, NY5.42MShares$169 Million0.01% of portfolio
- 
    
      William Blair Investment Management, LLC Chicago, IL3.91MShares$122 Million0.41% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $1.76B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...